Literature DB >> 6661348

Dose tolerance to lorazepam develop with once weekly dosing?

S E File, R G Lister.   

Abstract

The effect of once weekly administration of lorazepam (2.5 mg) to benzodiazepine-naive student volunteers was assessed in a number of performance tests and on self-ratings. Tolerance developed to the effects of lorazepam on finger-tapping and on self-ratings of dizziness. No tolerance was observed to the drug-induced impairment in a nonsense-syllable paired associate learning test or to the effects on self-ratings of sedation or on heart rate. It is suggested that the reduced impairment in the digit-symbol substitution test observed in weeks 2 and 3 of lorazepam treatment was due to a 'masked' practice effect rather than to tolerance. Test-retest correlation coefficients were calculated for all the tests used. The effect of lorazepam in each test was also correlated with its effect in the other tests. There were significant correlations in performance on placebo in the finger-tapping (r = 0.66), digit-symbol substitution (r = 0.94), symbol copying (r = 0.96) and nonsense-syllable learning (r = 0.74) tests. It is suggested that benzodiazepine experience should be given to drug-naive subjects before they are used in cross-over experiments that involve this class of compound, since the major change in impairment occurred between the first and second exposure to lorazepam.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6661348      PMCID: PMC1428347          DOI: 10.1111/j.1365-2125.1983.tb02235.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  13 in total

1.  Effects of benzodiazepines on psychomotor performance.

Authors:  J R Wittenborn
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

2.  Central nervous system and cardiovascular effects of lorazepam in man.

Authors:  H W Elliott; N Nomof; G Navarro; H W Ruelius; J A Knowles; W H Comer
Journal:  Clin Pharmacol Ther       Date:  1971 May-Jun       Impact factor: 6.875

Review 3.  Lorazepam: a review of its clinical pharmacological properties and therapeutic uses.

Authors:  B Ameer; D J Greenblatt
Journal:  Drugs       Date:  1981-03       Impact factor: 9.546

Review 4.  A review of the effects of diazepam on cognitive and psychomotor performance.

Authors:  R A Kleinknecht; D Donaldson
Journal:  J Nerv Ment Dis       Date:  1975-12       Impact factor: 2.254

Review 5.  Psychomotor function and psychoactive drugs.

Authors:  I Hindmarch
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

6.  Acute effects of temazepam and nitrazepam on psychomotor skills and memory.

Authors:  R Liljequist; M J Mattila
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1979-05

7.  Interaction between effects of caffeine and lorazepam in performance tests and self-ratings.

Authors:  S E File; A J Bond; R G Lister
Journal:  J Clin Psychopharmacol       Date:  1982-04       Impact factor: 3.153

8.  Benzodiazepine hypnotics increase heart rate during sleep.

Authors:  A Muzet; L C Johnson; C L Spinweber
Journal:  Sleep       Date:  1982       Impact factor: 5.849

9.  Caffeine antagonizes diazepam effects in man.

Authors:  M J Mattila; E Palva; K Savolainen
Journal:  Med Biol       Date:  1982-04

10.  Impaired performance and sedation after a single dose of lorazepam.

Authors:  S E File; A J Bond
Journal:  Psychopharmacology (Berl)       Date:  1979       Impact factor: 4.530

View more
  9 in total

1.  Simultaneous modeling of the pharmacokinetic and pharmacodynamic properties of benzodiazepines. I: Lorazepam.

Authors:  S K Gupta; E H Ellinwood; A M Nikaido; D G Heatherly
Journal:  J Pharmacokinet Biopharm       Date:  1990-04

2.  Behavioral analysis of diazepam-induced memory deficits: evidence for sedation-like effects.

Authors:  L E Kalynchuk; C H Beck
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

3.  Effects of repeated doses of fluvoxamine, mianserin and placebo on memory and measures of sedation.

Authors:  H V Curran; P Shine; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

4.  Influence of dosing regimen on alprazolam and metabolite serum concentrations and tolerance to sedative and psychomotor effects.

Authors:  R B Smith; P D Kroboth
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

5.  Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.

Authors:  H V Curran; W Schiwy; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

6.  Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.

Authors:  H V Curran; F Schifano; M Lader
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  The nature of lorazepam-induced amnesia.

Authors:  R G Lister; S E File
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

8.  Acute and subchronic effects of Org 2305 and diazepam on psychomotor performance in man.

Authors:  M J Mattila; J Koski; C Strömberg
Journal:  Br J Clin Pharmacol       Date:  1987-02       Impact factor: 4.335

9.  A comparison of the effects of lorazepam with those of propranolol on experimentally-induced anxiety and performance.

Authors:  S E File; R G Lister
Journal:  Br J Clin Pharmacol       Date:  1985-04       Impact factor: 4.335

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.